Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In cross-sectional studies, elevated plasma homocysteine levels have been associated with poor cognition and dementia. Studies of newly diagnosed dementia are required in order to establish whether the elevated homocysteine levels precede the onset of dementia or result from dementia-related nutritional and vitamin deficiencies. METHODS: A total of 1092 subjects without dementia (667 women and 425 men; mean age, 76 years) from the Framingham Study constituted our study sample. We examined the relation of the plasma total homocysteine level measured at base line and that measured eight years earlier to the risk of newly diagnosed dementia on follow-up. We used multivariable proportional-hazards regression to adjust for age, sex, apolipoprotein E genotype, vascular risk factors other than homocysteine, and plasma levels of folate and vitamins B12 and B6. RESULTS: Over a median follow-up period of eight years, dementia developed in 111 subjects, including 83 given a diagnosis of Alzheimer's disease. The multivariable-adjusted relative risk of dementia was 1.4 (95 percent confidence interval, 1.1 to 1.9) for each increase of 1 SD in the log-transformed homocysteine value either at base line or eight years earlier. The relative risk of Alzheimer's disease was 1.8 (95 percent confidence interval, 1.3 to 2.5) per increase of 1 SD at base line and 1.6 (95 percent confidence interval, 1.2 to 2.1) per increase of 1 SD eight years before base line. With a plasma homocysteine level greater than 14 micromol per liter, the risk of Alzheimer's disease nearly doubled. CONCLUSIONS: An increased plasma homocysteine level is a strong, independent risk factor for the development of dementia and Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adjudication for Alzheimer’s phenotypes was done by a committee41, comprising at least two neurologists and a neuropsychologist.”
From Clonal hematopoiesis is associated with protection from Alzheimer’s disease (2023) · cites this paper as [41]
In the citing paper
“Dementia diagnoses were made according to DSM‐IV criteria, based on longitudinal cognitive assessments, caregiver interviews, medical records, neuroimaging, and autopsy data when available.”
From Blood PCSK9 Impacts Alzheimer's Disease Risk in an APOE Genotype‐Dependent Manner: A Prospective Cohort Study (2026) · cites this paper as [18]
In the citing paper
“Overall, of the 19 selected cohort studies linking Hcy to the various cognitive outcomes, 12(63.2%) found the relationship in the hypothesized direction in the entire population that was studied and for most outcomes of interest [206,215,217,219,222-224,228,231,233-235]”
From Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis (2014) · cites this paper as [206]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,234
Homocysteine and Atherothrombosis
Welch, G. N., & Loscalzo, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804093381507 · Cited by 1,997
Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly Population
Selhub, J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510220049033 · Cited by 1,972
Self-citationBrookmeyer, R., Gray, S., & Kawas, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,787
A Prospective Study of Plasma Homocyst(e)ine and Risk of Myocardial Infarction in US Physicians
Stampfer, M. J. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490070059042 · Cited by 1,709
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590
Aging, energy, and oxidative stress in neurodegenerative diseases
Beal, M. F. (1995) · Annals of Neurology · doi:10.1002/ana.410380304 · Cited by 1,440
Research works printed but not linked: 3
- Berg L, 1988, Psychopharmacol Bull, 24, 637
- Levin ML, 1953, Acta Unio Int Contr Cancrum, 9, 531
- 1996, Fed Regist, 61, 8781
Cited by
Leisure Activities and the Risk of Dementia in the Elderly
Verghese, J., Lipton, R. B., Katz, M. J., Hall, C. B., Derby, C. A., Kuslansky, G., Ambrose, A. F., Sliwinski, M., & Buschke, H. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022252 · Cited by 1,961
Fluorescent and colorimetric probes for detection of thiols
Chen, X., Zhou, Y., Peng, X., & Yoon, J. (2010) · Chemical Society Reviews · doi:10.1039/b925092a · Cited by 1,580
Phosphorescent chemosensors based on heavy-metal complexes
Zhao, Q., Li, F., & Huang, C. (2010) · Chemical Society Reviews · doi:10.1039/b915340c · Cited by 1,249
(2014) · International Journal of Stroke · doi:10.1111/ijs.12374_18 · Cited by 1,166
O'Brien, J. T., Erkinjuntti, T., Reisberg, B., Roman, G., Sawada, T., Pantoni, L., Bowler, J. V., Ballard, C., DeCarli, C., Gorelick, P. B., et al. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00305-3 · Cited by 1,139
Choline: an essential nutrient for public health
Zeisel, S. H., & da Costa, K.-A. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2009.00246.x · Cited by 1,062
Craig, S. A. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.3.539 · Cited by 1,062
Facts and recommendations about total homocysteine determinations: an expert opinion
Refsum, H., Smith, A. D., Ueland, P. M., Nexo, E., Clarke, R., McPartlin, J., Johnston, C., Engbaek, F., Schneede, J., McPartlin, C., et al. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.021634 · Cited by 1,056
“A large prospective study showed that increased tHcy up to 11 years before the diagnosis of dementia is associated with twice the risk of Alzheimer disease (196).”
BackgroundB Vitamins and the Brain: Mechanisms, Dose and Efficacy—A Review
Kennedy, D. (2016) · Nutrients · doi:10.3390/nu8020068 · Cited by 1,055
“The “homocysteine hypothesis” originally stemmed from the observation that increased fasting plasma levels of the potentially toxic amino acid homocysteine were an independent predictor of cardiovascular disease [60,61],with this observation subsequently extended to cognitive function [62], Alzheimer’s disease and dem…”
BackgroundRecent progress in luminescent and colorimetric chemosensors for detection of thiols
Jung, H. S., Chen, X., Kim, J. S., & Yoon, J. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60024f · Cited by 882
Vitamin B12, folic acid, and the nervous system
Reynolds, E. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70598-1 · Cited by 860
Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders
Mattson, M. P., & Shea, T. B. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00032-8 · Cited by 847
Metal coordination in photoluminescent sensing
Liu, Z., He, W., & Guo, Z. (2013) · Chemical Society Reviews · doi:10.1039/c2cs35363f · Cited by 800
Aggregation of vascular risk factors and risk of incident Alzheimer disease
Luchsinger, J. A., Reitz, C., Honig, L. S., Tang, M. X., Shea, S., & Mayeux, R. (2005) · Neurology · doi:10.1212/01.wnl.0000172914.08967.dc · Cited by 790
“Diabetes (6–8), hyperlipidemia (9), hypertension (10), heart disease (11), smoking (12,13), homocysteine (14), and obesity (15) are associated with a higher risk of AD.”
BackgroundVeech, R. L. (2004) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.09.007 · Cited by 755
“The remaining 70–80% of Alzheimer’s disease have the same pathological findings of amyloid plaques, phosphorylated microtubular proteins and loss of hippocampal neurons associated with memory loss and increasing dementia, but from causes which include ischemia [64] mild trauma [65] elevated plasma homocystine [ 66 ] i…”
BackgroundHomocysteine Levels and the Risk of Osteoporotic Fracture
van Meurs, J. B. J., Dhonukshe-Rutten, R. A. M., Pluijm, S. M. F., van der Klift, M., de Jonge, R., Lindemans, J., de Groot, L. C. P. G. M., Hofman, A., Witteman, J. C. M., van Leeuwen, J. P. T. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032546 · Cited by 740
Cognitive impairment in hemodialysis patients is common
Murray, A. M., Tupper, D. E., Knopman, D. S., Gilbertson, D. T., Pederson, S. L., Li, S., Smith, G. E., Hochhalter, A. K., Collins, A. J., & Kane, R. L. (2006) · Neurology · doi:10.1212/01.wnl.0000225182.15532.40 · Cited by 712
Haussler, M. R., Jurutka, P. W., Mizwicki, M., & Norman, A. W. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.05.010 · Cited by 683
Schaefer, E. J., Bongard, V., Beiser, A. S., Lamon-Fava, S., Robins, S. J., Au, R., Tucker, K. L., Kyle, D. J., Wilson, P. W. F., & Wolf, P. A. (2006) · Archives of Neurology · doi:10.1001/archneur.63.11.1545 · Cited by 686
“Total plasma homocysteine concentrations were determined with the use of high-performance liquid chromatography with fluorometric detection.(4) The coefficient of variation for this assay was 9%.”
BackgroundMethodSelf-citationA Unique Approach to Development of Near-Infrared Fluorescent Sensors for in Vivo Imaging
Yuan, L., Lin, W., Zhao, S., Gao, W., Chen, B., He, L., & Zhu, S. (2012) · Journal of the American Chemical Society · doi:10.1021/ja305802v · Cited by 679
Beydoun, M. A., Beydoun, H. A., Gamaldo, A. A., Teel, A., Zonderman, A. B., & Wang, Y. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-643 · Cited by 671
“Accordingly, a potential influence of hyperhomocysteinemia on cognitive functioning among older adults was postulated and several studies were able to associate high levels of Hcy with increased risk of incident AD or all-cause dementia [206,217,224,228,233,234].”
BackgroundInfluentialYang, X., Guo, Y., & Strongin, R. M. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201103759 · Cited by 658
Singh, S., Padovani, D., Leslie, R. A., Chiku, T., & Banerjee, R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.010868 · Cited by 614
Involvement of oxidative stress in Alzheimer disease
Nunomura, A., Castellani, R. J., Zhu, X., Moreira, P. I., Perry, G., & Smith, M. A. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000228136.58062.bf · Cited by 611
Exercise, brain, and cognition across the life span.
Voss, M. W., Nagamatsu, L. S., Liu-Ambrose, T., & Kramer, A. F. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00210.2011 · Cited by 601
Posttraumatic stress disorder and risk of dementia among US veterans
Yaffe, K., Vittinghoff, E., Lindquist, K., Barnes, D., Covinsky, K. E., Neylan, T., Kluse, M., & Marmar, C. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.61 · Cited by 596
Detection of Homocysteine and Cysteine
Wang, W., Rusin, O., Xu, X., Kim, K. K., Escobedo, J. O., Fakayode, S. O., Fletcher, K. A., Lowry, M., Schowalter, C. M., Lawrence, C. M., et al. (2005) · Journal of the American Chemical Society · doi:10.1021/ja054962n · Cited by 593
Homocysteine as a Predictive Factor for Hip Fracture in Older Persons
McLean, R. R., Jacques, P. F., Selhub, J., Tucker, K. L., Samelson, E. J., Broe, K. E., Hannan, M. T., Cupples, L. A., & Kiel, D. P. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032739 · Cited by 589
Self-citationMethionine metabolism in health and cancer: a nexus of diet and precision medicine
Sanderson, S. M., Gao, X., Dai, Z., & Locasale, J. W. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0187-8 · Cited by 563
Casserly, I., & Topol, E. J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15900-x · Cited by 560
Aisen, P. S. (2008) · JAMA · doi:10.1001/jama.300.15.1774 · Cited by 557
“Studies have demonstrated a relationship between plasma homocysteine level and AD (including neuropathologically confirmed AD), and cognitive function in individuals without dementia(10,11); this relationship spans the normal range of homocysteine levels.(11) There is intriguing evidence that homocysteine levels may b…”
BackgroundThiol-addition reactions and their applications in thiol recognition
Yin, C., Huo, F., Zhang, J., Martínez-Máñez, R., Yang, Y., Lv, H., & Li, S. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60055f · Cited by 554
Homocysteine, B Vitamins, and Cognitive Impairment
Smith, A. D., & Refsum, H. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050947 · Cited by 513
Visual Detection of Cysteine and Homocysteine
Rusin, O., St. Luce, N. N., Agbaria, R. A., Escobedo, J. O., Jiang, S., Warner, I. M., Dawan, F. B., Lian, K., & Strongin, R. M. (2004) · Journal of the American Chemical Society · doi:10.1021/ja036297t · Cited by 516
Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment
Douaud, G., Refsum, H., de Jager, C. A., Jacoby, R., E. Nichols, T., Smith, S. M., & Smith, A. D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301816110 · Cited by 515
“Int J Geriatr Psychiatry 27(6):592–600.”
Zhang, M., Yu, M., Li, F., Zhu, M., Li, M., Gao, Y., Li, L., Liu, Z., Zhang, J., Zhang, D., et al. (2007) · Journal of the American Chemical Society · doi:10.1021/ja073140i · Cited by 502
Homocysteine and folate as risk factors for dementia and Alzheimer disease
Ravaglia, G., Forti, P., Maioli, F., Martelli, M., Servadei, L., Brunetti, N., Porcellini, E., & Licastro, F. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.3.636 · Cited by 500
“Only 2 longitudinal studies investigated the relation between hyperhomocysteinemia and risk of incident AD, but their results were inconsistent; the Framingham Study reported a strong association (17), and the Washington Heights–Inwood Columbia Ageing Project (WHICAP) reported no association (18).”
ResultInfluentialObeid, R., & Herrmann, W. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.04.088 · Cited by 490
Mattson, M. P. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:3:2:65 · Cited by 475
“Three such factors are caloric intake (Mattson et al., 2000; Luchsinger et al., 2002), cholesterol/fat intake (Refolo et al., 2000; Burns and Duff, 2002), and folate intake (Kruman et al., 2002; Seshadri et al., 2002).”
Cognitive Impairment in Chronic Kidney Disease
Kurella, M., Chertow, G. M., Luan, J., & Yaffe, K. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52508.x · Cited by 472
“Increased levels of homocysteine and inflammatory cytokines are thought to play a role in accelerated atherosclerosis in CKD and ESRD and have been associated with dementia in the general population.(30,31) Anemia has been described as a risk factor for cognitive impairment in persons with ESRD.”
BackgroundAge-Specific Epigenetic Drift in Late-Onset Alzheimer's Disease
Wang, S.-C., Oelze, B., & Schumacher, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002698 · Cited by 466
“Nevertheless, the occurrence of abnormal methylation pathways in the brain that precede pathological findings and dementia supports our model that epigenetic drift may be one contributor to LOAD predisposition [26–29].”
BackgroundKurella, M., Chertow, G. M., Fried, L. F., Cummings, S. R., Harris, T., Simonsick, E., Satterfield, S., Ayonayon, H., & Yaffe, K. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010005 · Cited by 458
“We could not evaluate the contribution of other proposed causative factors, such as elevated levels of homocysteine and oxidative stress (27,28).”
Backgroundde Jager, C. A., Oulhaj, A., Jacoby, R., Refsum, H., & Smith, A. D. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2758 · Cited by 457
“Patients with Alzheimer’s disease (AD) have higher plasma tHcy than normal older people (Clarke et al., 1998; McCaddon et al., 1998; Seshadri et al., 2002; Smith, 2008), and tHcy influences the rate of cognitive decline (Oulhaj et al., 2010).”
BackgroundIncreased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease
Wang, J., Xiong, S., Xie, C., Markesbery, W. R., & Lovell, M. A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03053.x · Cited by 451
“AD is associated with several risk factors, including age, genetic factors, presence of apolipoprotein E-4 alleles, educational attainment, head injury, hyperhomocysteinemia and diet (Schofield and Mayeux 1998; Seshadri et al. 2002).”
BackgroundAn integrated epigenetic and genetic approach to common human disease
BJORNSSON, H. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.06.009 · Cited by 448
Pfeiffer, C. M., Caudill, S. P., Gunter, E. W., Osterloh, J., & Sampson, E. J. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn.82.2.442 · Cited by 436
Dietary factors and Alzheimer's disease
Luchsinger, J. A., & Mayeux, R. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00878-6 · Cited by 433
Grammas, P. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-26 · Cited by 432
“Numerous studies link vascular risk factors to cognitive decline and dementia in the elderly [3-32].”
BackgroundInverse association between cancer and Alzheimer's disease: results from the Framingham Heart Study
Driver, J. A., Beiser, A., Au, R., Kreger, B. E., Splansky, G. L., Kurth, T., Kiel, D. P., Lu, K. P., Seshadri, S., & Wolf, P. A. (2012) · BMJ · doi:10.1136/bmj.e1442 · Cited by 425
Self-citationThe Molecular and Cellular Effect of Homocysteine Metabolism Imbalance on Human Health
Škovierová, H., Vidomanová, E., Mahmood, S., Sopková, J., Drgová, A., Červeňová, T., Halašová, E., & Lehotský, J. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101733 · Cited by 422
Cognitive Impairment in the Aging Dialysis and Chronic Kidney Disease Populations: An Occult Burden
Murray, A. M. (2008) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2008.01.010 · Cited by 416
“Most hemodialysis patients are vasculopaths, with high rates of hypertension (80%), diabetes (60%) (14), markedly elevated levels of inflammatory markers and homocysteine (27), vascular endothelial dysfunction (28), cardiovascular events including stroke (29,30), and carotid atherosclerosis (31), all of which contribu…”
BackgroundFuso, A., Seminara, L., Cavallaro, R. A., D'Anselmi, F., & Scarpa, S. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.09.007 · Cited by 406
“Particular attention has been dedicated to the regulation of gand h-secretases, in order to reduce the amyloidogenic cutting of APP (Ohno et al., 2004; Selkoe, 2001 ).”
BackgroundChromogenic/Fluorogenic Ensemble Chemosensing Systems
Wu, J., Kwon, B., Liu, W., Anslyn, E. V., Wang, P., & Kim, J. S. (2015) · Chemical Reviews · doi:10.1021/cr500553d · Cited by 402
Risks of Copper and Iron Toxicity during Aging in Humans
Brewer, G. J. (2010) · Chemical Research in Toxicology · doi:10.1021/tx900338d · Cited by 395
A Controlled Trial of Homocysteine Lowering and Cognitive Performance
McMahon, J. A., Green, T. J., Skeaff, C. M., Knight, R. G., Mann, J. I., & Williams, S. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054025 · Cited by 396
Bright-Yellow-Emissive N-Doped Carbon Dots: Preparation, Cellular Imaging, and Bifunctional Sensing
Jiang, K., Sun, S., Zhang, L., Wang, Y., Cai, C., & Lin, H. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b07255 · Cited by 395
Kurella Tamura, M., Wadley, V., Yaffe, K., McClure, L. A., Howard, G., Go, R., Allman, R. M., Warnock, D. G., & McClellan, W. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.05.004 · Cited by 388
Role of Folate in Colon Cancer Development and Progression
Kim, Y.-I. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.11.3731s · Cited by 386
Kaur, K., Saini, R., Kumar, A., Luxami, V., Kaur, N., Singh, P., & Kumar, S. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.04.013 · Cited by 384
Manjare, S. T., Kim, Y., & Churchill, D. G. (2014) · Accounts of Chemical Research · doi:10.1021/ar500187v · Cited by 383
Ho, P. I., Ortiz, D., Rogers, E., & Shea, T. B. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10416 · Cited by 381
“Plasma HC has been reported to be elevated in some (Joosten et al., 1997; Clarke et al., 1998; Seshadri et al., 2002), but not all (Fekkes et al.”
BackgroundResultThe metabolism and significance of homocysteine in nutrition and health
Kumar, A., Palfrey, H. A., Pathak, R., Kadowitz, P. J., Gettys, T. W., & Murthy, S. N. (2017) · Nutrition & Metabolism · doi:10.1186/s12986-017-0233-z · Cited by 378
Lin, W., Yuan, L., Cao, Z., Feng, Y., & Long, L. (2009) · Chemistry – A European Journal · doi:10.1002/chem.200802751 · Cited by 367
Liu-Ambrose, T., Nagamatsu, L. S., Voss, M. W., Khan, K. M., & Handy, T. C. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.05.010 · Cited by 363
“, 2005), Alzheimer’s disease (Seshadri et al., 2002), and cerebral white matter lesions (Vermeer et al.”
InfluentialHomocysteine and Dementia: An International Consensus Statement
Smith, A. D., Refsum, H., Bottiglieri, T., Fenech, M., Hooshmand, B., McCaddon, A., Miller, J. W., Rosenberg, I. H., & Obeid, R. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-171042 · Cited by 360
“The intervals between blood sampling to measure tHcy and diagnosis of cognitive impairment or dementia were up to 13 years in the Framingham study [18] and 35 years in the Gothenburg Women Study [19].”
MethodSelf-citationThe protocols for the 10/66 dementia research group population-based research programme
Prince, M., Ferri, C. P., Acosta, D., Albanese, E., Arizaga, R., Dewey, M., Gavrilova, S. I., Guerra, M., Huang, Y., Jacob, K., et al. (2007) · BMC Public Health · doi:10.1186/1471-2458-7-165 · Cited by 357
Tucker, K. L., Qiao, N., Scott, T., Rosenberg, I., & Spiro, A. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.3.627 · Cited by 351
Self-citationSolfrizzi, V., Custodero, C., Lozupone, M., Imbimbo, B. P., Valiani, V., Agosti, P., Schilardi, A., D’Introno, A., La Montagna, M., Calvani, M., et al. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170248 · Cited by 352
“Additionally, vitamin B12, along with folate and vitamin B6, are key actors in the homocysteine cycle, and the disruption of this cycle can lead to elevated homocysteine, which has been found among individuals with dementia [79] and has been shown to predict dementia prospectively [80].”
Homocysteine and Alzheimer's disease
Morris, M. S. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00438-1 · Cited by 332
Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians
Wong, C. W., Yanagi, Y., Lee, W.-K., Ogura, Y., Yeo, I., Wong, T. Y., & Cheung, C. M. G. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.04.002 · Cited by 346
Oxidative Stress Signaling in Alzheimers Disease
Su, B., Wang, X., Nunomura, A., Moreira, P., Lee, H.-G., Perry, G., Smith, M., & Zhu, X. (2008) · Current Alzheimer Research · doi:10.2174/156720508786898451 · Cited by 344
“A recent review by Reddy and Beal clearly reviewed the effect of Aβ on mitochondrial dysfunction [31]; 4) Hyperhomocysteinemia is a strong, independent risk factor for the development of AD [32] and homocysteine inhibits several genes encoding mitochondrial proteins and promotes ROS production [33].”
BackgroundA life-course approach to the aetiology of late-onset dementias
Whalley, L. J., Dick, F. D., & McNeill, G. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70286-6 · Cited by 343
Stroke and the Risk of Alzheimer Disease
Honig, L. S., Tang, M.-X., Albert, S., Costa, R., Luchsinger, J., Manly, J., Stern, Y., & Mayeux, R. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1707 · Cited by 343
Seliger, S. L., Siscovick, D. S., Stehman-Breen, C. O., Gillen, D. L., Fitzpatrick, A., Bleyer, A., & Kuller, L. H. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000131529.60019.fa · Cited by 343
“One factor may be elevated homocysteine, which is common even in moderate renal insufficiency (39) and was strongly associated with incident dementia in an analysis from the Framingham Study (40).”
BackgroundYang, X.-F., Huang, Q., Zhong, Y., Li, Z., Li, H., Lowry, M., Escobedo, J. O., & Strongin, R. M. (2014) · Chemical Science · doi:10.1039/c4sc00308j · Cited by 343
The Cambridge Handbook of Age and Ageing
(2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511610714 · Cited by 336
Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics
Shaw, L. M., Korecka, M., Clark, C. M., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2176 · Cited by 339
Cortes-Canteli, M., Paul, J., Norris, E. H., Bronstein, R., Ahn, H. J., Zamolodchikov, D., Bhuvanendran, S., Fenz, K. M., & Strickland, S. (2010) · Neuron · doi:10.1016/j.neuron.2010.05.014 · Cited by 339
Plasma β-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy
Gurol, M. E., Irizarry, M. C., Smith, E. E., Raju, S., Diaz-Arrastia, R., Bottiglieri, T., Rosand, J., Growdon, J. H., & Greenberg, S. M. (2006) · Neurology · doi:10.1212/01.wnl.0000191403.95453.6a · Cited by 339
Li, H., Fan, J., Wang, J., Tian, M., Du, J., Sun, S., Sun, P., & Peng, X. (2009) · Chemical Communications · doi:10.1039/b907511a · Cited by 339
Quadri, P., Fragiacomo, C., Pezzati, R., Zanda, E., Forloni, G., Tettamanti, M., & Lucca, U. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.1.114 · Cited by 339
“In the Framingham longitudinal study (27), an elevated plasma total homocysteine concentration in elderly subjects free of dementia was related to the risk of newly diagnosed dementia or AD over the subsequent 8 y.”
BackgroundResultHomocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction
Hassan, A. (2004) · Brain · doi:10.1093/brain/awh023 · Cited by 338
Causes of oxidative stress in Alzheimer disease
Zhu, X., Su, B., Wang, X., Smith, M. A., & Perry, G. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7218-4 · Cited by 336
Hersi, M., Irvine, B., Gupta, P., Gomes, J., Birkett, N., & Krewski, D. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2017.03.006 · Cited by 332
Functional synthetic probes for selective targeting and multi-analyte detection and imaging
Yue, Y., Huo, F., Cheng, F., Zhu, X., Mafireyi, T., Strongin, R. M., & Yin, C. (2019) · Chemical Society Reviews · doi:10.1039/c8cs01006d · Cited by 330
Chen, X., Jhee, K.-H., & Kruger, W. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400481200 · Cited by 330
Hyman, L. M., & Franz, K. J. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.03.009 · Cited by 325
Prevalence and Correlates of Silent Cerebral Infarcts in the Framingham Offspring Study
Das, R. R., Seshadri, S., Beiser, A. S., Kelly-Hayes, M., Au, R., Himali, J. J., Kase, C. S., Benjamin, E. J., Polak, J. F., O'Donnell, C. J., et al. (2008) · Stroke · doi:10.1161/strokeaha.108.516575 · Cited by 324
Self-citationCardiovascular risk factors and future risk of Alzheimer’s disease
de Bruijn, R. F., & Ikram, M. A. (2014) · BMC Medicine · doi:10.1186/s12916-014-0130-5 · Cited by 322
“Consequently, high plasma homocysteine levels have been related to an increased risk of AD [118].”
BackgroundLiu‐Ambrose, T., Donaldson, M. G., Ahamed, Y., Graf, P., Cook, W. L., Close, J., Lord, S. R., & Khan, K. M. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01931.x · Cited by 322
Homocysteine and Alzheimer's disease
LEBOEUF, R. (2003) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(03)00032-4 · Cited by 321
A Ratiometric Fluorescent Probe for Cysteine and Homocysteine Displaying a Large Emission Shift
Lin, W., Long, L., Yuan, L., Cao, Z., Chen, B., & Tan, W. (2008) · Organic Letters · doi:10.1021/ol802436j · Cited by 319
Han, B., Yuan, J., & Wang, E. (2009) · Analytical Chemistry · doi:10.1021/ac900769h · Cited by 316
Li, S., Zhang, H., Zhu, M., Kuang, Z., Li, X., Xu, F., Miao, S., Zhang, Z., Lou, X., Li, H., et al. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00759 · Cited by 309
Mechanisms of homocysteine toxicity in humans
Perła-Kaján, J., Twardowski, T., & Jakubowski, H. (2007) · Amino Acids · doi:10.1007/s00726-006-0432-9 · Cited by 313
“The formation of such clots could directly contribute to the increased risk of thrombosis in hyperhomocysteinemia ( Sauls et al., 2003 ).”
BackgroundThe Treatment of Hyperhomocysteinemia
Maron, B. A., & Loscalzo, J. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.041807.123308 · Cited by 313
“vascular function and neuroexcitation may contribute to the development and progression of dementia-type disorders (6,7).”
BackgroundYaffe, K., Ackerson, L., Tamura, M. K., Le Blanc, P., Kusek, J. W., Sehgal, A. R., Cohen, D., Anderson, C., Appel, L., DeSalvo, K., et al. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02670.x · Cited by 313
Nonalcoholic fatty liver disease and aging: epidemiology to management.
Bertolotti, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i39.14185 · Cited by 270
70-year legacy of the Framingham Heart Study
Andersson, C., Johnson, A. D., Benjamin, E. J., Levy, D., & Vasan, R. S. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0202-5 · Cited by 305
Metadata
- Authors
- Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A.
- Affiliations
- Boston University (US)
- Tufts University (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-02-14
- Volume
- 346
- Issue
- 7
- Pages
- 476-483
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2052588755
- Cited by
- 3,237
- References
- 55
- Citations by year
- 2026: 49 · 2025: 61 · 2024: 82 · 2023: 79 · 2022: 90 · 2021: 102 · 2020: 91 · 2019: 133 · 2018: 132 · 2017: 138 · 2016: 138 · 2015: 149 · 2014: 174 · 2013: 154 · 2012: 155
- FWCI
- 111.96
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01hc038038-022)
- National Institute on Aging (5R01 AG 08122-11, 5R01-AG16495-02, R01AG016495, R01AG008122)
- National Heart, Lung, and Blood Institute (N01-HC-38038)
- National Institute of Neurological Disorders and Stroke (5R01 NS 17950-19, R01NS017950)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- plasma homocysteine, dementia, Alzheimer's disease, risk factors, newly diagnosed dementia, folic acid, vitamin B12, vitamin B6, apolipoprotein E, Framingham Heart Study, cognitive decline
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Apolipoproteins E, Dementia, Female, Homocysteine, Humans, Male, Risk Factors, Cohort Studies, Confounding Factors, Epidemiologic, Multivariate Analysis, Proportional Hazards Models, Hyperhomocysteinemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.